These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34265241)

  • 1. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.
    Asundi A; O'Leary C; Bhadelia N
    Cell Host Microbe; 2021 Jul; 29(7):1036-1039. PubMed ID: 34265241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines for COVID-19: Where do we stand in 2021?
    Sharma K; Koirala A; Nicolopoulos K; Chiu C; Wood N; Britton PN
    Paediatr Respir Rev; 2021 Sep; 39():22-31. PubMed ID: 34362666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine: Practical Clinical Considerations.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 May; 174(5):694. PubMed ID: 33769829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID vaccine challenges that lie ahead.
    Nature; 2020 Nov; 587(7835):522. PubMed ID: 33235368
    [No Abstract]   [Full Text] [Related]  

  • 7. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Vaccine Inequity.
    Seegert L
    Am J Nurs; 2022 Apr; 122(4):18-19. PubMed ID: 35348510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 - Inequities, the third wave and vaccination.
    Govender I
    S Afr Fam Pract (2004); 2021 Aug; 63(1):e1-e2. PubMed ID: 34476960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India's COVID-vaccine woes - by the numbers.
    Padma TV
    Nature; 2021 Apr; 592(7855):500-501. PubMed ID: 33854229
    [No Abstract]   [Full Text] [Related]  

  • 12. Status of vaccine development for COVID-19.
    Mendes A
    Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
    [No Abstract]   [Full Text] [Related]  

  • 13. Transforming COVID-19 vaccines into vaccination : Challenges and opportunities for management scientists.
    Dai T; Song JS
    Health Care Manag Sci; 2021 Sep; 24(3):455-459. PubMed ID: 34132977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canada is no global health leader on COVID-19 vaccine equity.
    Houston AR; Murthy S
    Lancet; 2021 May; 397(10287):1803. PubMed ID: 33992135
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.
    Mallapaty S
    Nature; 2021 Jun; 594(7862):161-162. PubMed ID: 34089030
    [No Abstract]   [Full Text] [Related]  

  • 16. Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.
    Quinn SC; Jamison AM; Freimuth V
    Am J Public Health; 2021 Mar; 111(3):355-358. PubMed ID: 33237801
    [No Abstract]   [Full Text] [Related]  

  • 17. The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
    Ning C; Wang H; Wu J; Chen Q; Pei H; Gao H
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free licensing of vaccines to end the COVID-19 crisis.
    Bozorgmehr K; Jahn R; Stuckler D; McKee M
    Lancet; 2021 Apr; 397(10281):1261-1262. PubMed ID: 33743843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.